Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-20 5:15 pm Purchase | 2026-06-30 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 17,428 1.500% | 4,301![]() (+32.76%) | Filing History |
| 2025-03-04 5:34 pm Sale | 2025-02-27 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 13,127 9.990% | -8,423![]() (-39.09%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-09-30 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 21,550 19.990% | 16,639![]() (+338.81%) | Filing History |
| 2024-03-26 4:30 pm Purchase | 2024-03-26 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 4,911 15.600% | 2,515![]() (+104.97%) | Filing History |
| 2024-01-30 4:05 pm Purchase | 2024-01-30 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 2,396 9.900% | 948![]() (+65.47%) | Filing History |
| 2023-03-08 5:22 pm Purchase | 2023-02-27 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 1,448 8.100% | 1,448![]() (New Position) | Filing History |
| 2022-12-19 06:05 am Purchase | 2022-12-08 | 13G | ARIDIS PHARMACEUTICALS INC ARDS | Cystic Fibrosis Foundation | 5,168,732 19.900% | 5,168,732![]() (New Position) | Filing History |

